Cabozantinib in advanced renal cell carcinoma: a METEOR impact on clinical practice

por Grassi, Paolo, Verzoni, Elena, Mennitto, Alessia, Procopio, Giuseppe
Publicado 2016

Predicting Molecular Models: Where Are We Going?

por Ratta, Raffaele, Verzoni, Elena, Grassi, Paolo, Niger, Monica, Procopio, Giuseppe
Publicado 2015

Response to Targeted Therapy in Urachal Adenocarcinoma

por Testa, Isabella, Verzoni, Elena, Grassi, Paolo, Colecchia, Maurizio, Panzone, Filomena, Procopio, Giuseppe
Publicado 2014

Cabozantinib in the treatment of advanced renal cell carcinoma: design, development, and potential place in the therapy

por Grassi, Paolo, Verzoni, Elena, Ratta, Raffaele, Mennitto, Alessia, de Braud, Filippo, Procopio, Giuseppe
Publicado 2016

BONSAI-2 study: Nivolumab as therapeutic option after cabozantinib failure in metastatic collecting duct carcinoma patients

por Buti, Sebastiano, Trentini, Francesca, Sepe, Pierangela, Claps, Melanie, Isella, Luca, Verzoni, Elena, Procopio, Giuseppe
Publicado 2022

The Evaluation of Response to Immunotherapy in Metastatic Renal Cell Carcinoma: Open Challenges in the Clinical Practice

por Raimondi, Alessandra, Randon, Giovanni, Sepe, Pierangela, Claps, Melanie, Verzoni, Elena, de Braud, Filippo, Procopio, Giuseppe
Publicado 2019

Targeted treatments in advanced renal cell carcinoma: focus on axitinib

por Verzoni, Elena, Grassi, Paolo, Testa, Isabella, Iacovelli, Roberto, Biondani, Pamela, Garanzini, Enrico, De Braud, Filippo, Procopio, Giuseppe
Publicado 2014

Characteristics and Treatment Challenges of Non-Clear Cell Renal Cell Carcinoma

por Sepe, Pierangela, Ottini, Arianna, Pircher, Chiara Carlotta, Franza, Andrea, Claps, Melanie, Guadalupi, Valentina, Verzoni, Elena, Procopio, Giuseppe
Publicado 2021

Does Dose Modification Affect Efficacy of First-Line Pazopanib in Metastatic Renal Cell Carcinoma?

por Grassi, Paolo, Verzoni, Elena, Ratta, Raffaele, Porcu, Luca, Prisciandaro, Michele, Mennitto, Alessia, Calareso, Giuseppina, de Braud, Filippo, Procopio, Giuseppe
Publicado 2017

Predictive Biomarkers of Response to Immunotherapy in Metastatic Renal Cell Cancer

por Raimondi, Alessandra, Sepe, Pierangela, Zattarin, Emma, Mennitto, Alessia, Stellato, Marco, Claps, Melanie, Guadalupi, Valentina, Verzoni, Elena, de Braud, Filippo, Procopio, Giuseppe
Publicado 2020

Could Circulating Tumor Cells and ARV7 Detection Improve Clinical Decisions in Metastatic Castration-Resistant Prostate Cancer? The Istituto Nazionale dei Tumori (INT) Experience

por Sepe, Pierangela, Verzoni, Elena, Miodini, Patrizia, Claps, Melanie, Ratta, Raffaele, Martinetti, Antonia, Mennitto, Roberta, Sottotetti, Elisa, Procopio, Giuseppe, Cappelletti, Vera, Daidone, Maria Grazia
Publicado 2019

Integrative Transcriptomic Analysis Reveals Distinctive Molecular Traits and Novel Subtypes of Collecting Duct Carcinoma

por Gargiuli, Chiara, Sepe, Pierangela, Tessari, Anna, Sheetz, Tyler, Colecchia, Maurizio, de Braud, Filippo Guglielmo Maria, Procopio, Giuseppe, Sensi, Marialuisa, Verzoni, Elena, Dugo, Matteo
Publicado 2021

Optimal Choice of Adjuvant Treatment for Renal Cell Carcinoma Following Nephrectomy

por Bottiglieri, Achille, Sepe, Pierangela, Stellato, Marco, Pircher, Chiara, Fotia, Giuseppe, Leone, Alberto Giovanni, Guadalupi, Valentina, Claps, Melanie, Giannatempo, Patrizia, Verzoni, Elena, Procopio, Giuseppe
Publicado 2022

Combination Therapy in Renal Cell Carcinoma: the Best Choice for Every Patient?

por Rossi, Ernesto, Bersanelli, Melissa, Gelibter, Alain Jonathan, Borsellino, Nicolò, Caserta, Claudia, Doni, Laura, Maruzzo, Marco, Mosca, Alessandra, Pisano, Carmela, Verzoni, Elena, Zucali, Paolo Andrea
Publicado 2021

Tivozanib in Patients with Advanced Renal Cell Carcinoma Previously Treated with Axitinib: Subgroup Analysis from TIVO-3

por Meza, Luis, McDermott, David F, Escudier, Bernard, Hutson, Thomas E, Porta, Camillo, Verzoni, Elena, Atkins, Michael B, Kasturi, Vijay, Pal, Sumanta K, Rini, Brian
Publicado 2022

Analysis of Single Circulating Tumor Cells in Renal Cell Carcinoma Reveals Phenotypic Heterogeneity and Genomic Alterations Related to Progression

por Cappelletti, Vera, Verzoni, Elena, Ratta, Raffaele, Vismara, Marta, Silvestri, Marco, Montone, Rosanna, Miodini, Patrizia, Reduzzi, Carolina, Claps, Melanie, Sepe, Pierangela, Daidone, Maria Grazia, Procopio, Giuseppe
Publicado 2020

Angiogenesis and Immunity in Renal Carcinoma: Can We Turn an Unhappy Relationship into a Happy Marriage?

por Mennitto, Alessia, Huber, Veronica, Ratta, Raffaele, Sepe, Pierangela, de Braud, Filippo, Procopio, Giuseppe, Guadalupi, Valentina, Claps, Mélanie, Stellato, Marco, Daveri, Elena, Rivoltini, Licia, Verzoni, Elena
Publicado 2020

Achieving Consensus for Management of Hormone-Sensitive, Low-Volume Metastatic Prostate Cancer in Italy

por Verzoni, Elena, Pappagallo, Giovanni, Alongi, Filippo, Arcangeli, Stefano, Francolini, Giulio, Galanti, Daniele, Galli, Luca, Maruzzo, Marco, Rossetti, Sabrina, Siepe, Giambattista, Triggiani, Luca, Zucali, Paolo Andrea, D’Angelillo, Rolando Maria
Publicado 2022

Prognostic Value of Thyroid Hormone Ratio in Patients With Advanced Metastatic Renal Cell Carcinoma: Results From the Threefour Study (Meet-URO 14)

por Maruzzo, Marco, Verzoni, Elena, Vitale, Maria Giuseppa, Dionese, Michele, Buti, Sebastiano, Galli, Luca, Zivi, Andrea, Watutantrige-Fernando, Sara, Zielli, Teresa, Zanardi, Elisa, Sabbatini, Roberto, Basso, Umberto, Zagonel, Vittorina, Procopio, Giuseppe
Publicado 2021

The amount of DNA combined with TP53 mutations in liquid biopsy is associated with clinical outcome of renal cancer patients treated with immunotherapy and VEGFR-TKIs

por Del Re, Marzia, Crucitta, Stefania, Paolieri, Federico, Cucchiara, Federico, Verzoni, Elena, Bloise, Francesco, Ciampi, Raffaele, Mercinelli, Chiara, Capuano, Annalisa, Sportiello, Liberata, Martinetti, Antonia, Procopio, Giuseppe, Galli, Luca, Porta, Camillo, Bracarda, Sergio, Danesi, Romano
Publicado 2022